Skip to main content
  • EMEA
  • MedTechPharmaceuticals / BioTech

Clinical Performance Studies with Companion Diagnostic (CDx) Devices

Special considerations for conducting clinical performance studies for companion diagnostics under the European IVDD and IVDR

  • Asia Pacific
  • MedTech

Australia Will Develop UDI System for Medical Devices Following New Regulatory Amendment

An amendment to Australia's therapeutic goods act 1989 calls for the creation of a unique device identification (UDI) system for medical devices.

  • North America
  • MedTech

US FDA Readies Transition Plans for COVID-19 Medical Device Enforcement Policies

New guidance from the US Food and Drug Administration explains a phased transition plan for medical devices currently covered by agency enforcement policies devised to address the COVID-19 public health emergency.

  • EMEA
  • MedTech

Norwegian Language Requirement Will Apply Following MDR Implementation

The Norwegian medicines agency (NoMA) has confirmed that, in order to be marketed in Norway, medical devices must include labeling and instructions for use (IFUs) in the Norwegian language.

  • EMEA
  • MedTech

Annex XIV of the European MDR and Clinical Development Plans for Medical Devices

The European medical devices regulation (MDR) requires manufacturers to establish clinical development plans (CDP). Learn more about EU MDR requirements at Emergo by UL.

  • Latin America
  • MedTechPharmaceuticals / BioTech

New Brazil INMETRO Ordinance Eases Inspection and Documentation Requirements

In Brazil, a new ordinance was published by the National Institute of Metrology, Standardization and Industrial Quality (INMETRO), providing updated conformity assessment standards and documentation requirements.

  • EMEA
  • MedTech

Eudamed Actor Module FAQ Now Live

The main reason for an economic operator to register in Eudamed has to do with the Single Registration Number (SRN).

  • Asia PacificEMEAGlobalLatin AmericaNorth America
  • MedTech

MDSAP Council Updates Guidance on Conformity Assessments and Related Requirements

The participating regulators in the medical device single audit program (MDSAP) issued a new guidance documents that is consolidated from two existing documents and expanded with additional annexes.

  • North America
  • MedTechPharmaceuticals / BioTech

US FDA 2020 Agenda Includes ISO 13485 Harmonization, De Novo Classification Scheme

The US Food and Drug Administration plans a final rule for De Novo medical device classification as well as a proposed rule for closer harmonization to ISO 13485:2016 quality management system requirements for later in 2020.

  • Asia Pacific
  • MedTech

Japanese Regulators Extend Medical Device Single Audit Program (MDSAP) Pilot

Updated Japan MHLW requirements for MDSAP report submissions take effect in April 2022